The BJC Learning Hub: Amyloidosis was developed in collaboration with the
National Amyloidosis Centre, Royal Free Hospital, London
Funding for this educational activity has come from multiple pharmaceutical industry sponsors.
Further details of each company’s involvement can be found below.
“Amyloidosis: a comprehensive guide”, Masterclasses and video guides: Sponsored by Pfizer Limited. Pfizer has had no involvement or influence over the content of this educational material.
“Amyloidosis: a comprehensive guide”, Masterclasses and video guides: This activity has been funded by Bayer plc. through a reactive sponsorship. Bayer plc has had no involvement in the development of this material, nor influence over its content.
“Amyloidosis: a comprehensive guide” and “Hiding in plain sight”: AstraZeneca has provided a sponsorship towards this independent programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence.
Cardiac amyloidosis – the deposition of amyloid fibrils in the tissues of the heart – is now known to be more common than previously believed.1
The prognosis for patients with amyloidosis has improved thanks to developments in diagnostic technology and treatment options, but successful treatment depends on early identification and referral to specialist services.1
This series of resources, developed by the BJC in collaboration with the National Amyloidosis Centre in London, aims to equip you with the skills to spot the warning signs of amyloidosis in your patients so you can help them access the treatment they need.
These recorded presentations provide a comprehensive guide for all members of the cardiovascular and primary care teams on what to look for, and what to do if you suspect amyloidosis.
An outline of the three most common forms of amyloidosis, the diagnostic procedures to know about, and treatment approaches.
Three case studies reflecting real amyloidosis patients – including differential diagnoses, and the comorbidities or confounding factors to be aware of.
Three short educational videos in the BJC’s “Masterclass” video series, covering key aspects of cardiac amyloidosis diagnosis and care. Filmed with a range of clinical and laboratory experts, these videos distil all the essential information into practical advice for clinicians.
The National Amyloidosis Centre – Video guides for you and your patients
These short videos provide an overview of the services and specialist staff available when you refer patients to the National Amyloidosis Centre (NAC), based at the Royal Free Hospital in London.
Reference:
1. Fontana M et al. JACC: Cardiovasc Imaging 2025;18:478–499.
You need to be a member to print this page.
Find out more about our membership benefits
You need to be a member to download PDF's.
Find out more about our membership benefits
